# DESCRIPTION

- introduce pregnancy prognosis method

## BACKGROUND

- introduce maternal fetal wellbeing and obstetric care

### Gestational Trophoblastic Diseases

- define gestational trophoblastic diseases
- limitations of hCG tests in diagnosing GTD

### Hyperemesis Gravidarum

- define hyperemesis gravidarum
- limitations of current management approaches
- potential link to hCG levels

### Pre-Eclampsia

- define pre-eclampsia and its effects

### Multiple Pregnancy.

- define multiple pregnancy and detection methods

### Spontaneous Abortion or Miscarriage

- define spontaneous abortion and its prevalence

### Embryo/Early Pregnancy

- introduce hCG and its isoforms
- describe hCGh and its significance
- summarize limitations of current hCG studies
- motivate embryo proteomic profiling
- describe US2009/0075293 method
- introduce present invention method
- describe direct mass spectral analysis
- define "direct mass spectral analysis"
- describe sample preparation and analysis
- define "embryo" and "prognosis for a pregnancy"
- describe method for providing a prognosis
- describe disorders of pregnancy
- describe sample types and collection methods
- describe sample dilution and processing
- describe direct mass spectral analysis parameters
- describe data processing and normalization
- define mass spectra analysis
- calculate relative intensity of mass regions
- create reference spectral model
- create disease model
- compare reference and disease models
- identify hot spots
- provide prognosis for pregnancy
- detect chromosomal abnormalities
- provide prognosis for successful embryo implantation
- detect multiple gestations
- detect pre-eclampsia
- detect hyperemesis gravidarum
- detect gestational trophoblastic disease
- analyze mass spectra using computer software
- perform direct mass spectral analysis
- provide prognosis for pregnancy using mass spectral analysis

## EXAMPLE 1 GESTATIONAL TROPHOBLASTIC DISEASE

- present MALDI analysis method for GTD condition

### Results

- analyze urine samples from patients with normal pregnancy and GTD

## EXAMPLE 2 HYPEREMESIS GRAVIDARUM

- describe method to identify molecular forms of hCG

### Results

- analyze urine samples from patients with normal pregnancy and hyperemesis gravidarum

## EXAMPLE 3 PRE-ECLAMPSIA

- analyze urine by MALDI-ToF MS for protein profile changes

## EXAMPLE 4 EMBRYO/EARLY PREGNANCY

- present method for MALDI ToF MS analysis of m/z variants

### Results

- analyze urine and embryo culture fluid samples from patients with normal pregnancy

## EXAMPLE 5 PREDICTING PREGNANCY OUTCOMES USING A NON-INVASIVE ANALYSIS OF SECRETOME PARAMETERS IN SPENT BLASTOCYST CULTURE MEDIA USING MALDI-TOF MS

### Study Design, Size, Duration:

- describe study design and size

### Materials, Settings and Methods:

- describe materials and methods used

### Main Results and the Role of Chance:

- present main results and role of chance

## EXAMPLE 6 SPONTANEOUS ABORTION/MISCARRIAGE

- describe study examining urine samples from women testing positive for pregnancy

### Materials, Settings and Methods:

- describe materials and methods used

### Main Results and the Role of Chance:

- present main results and role of chance
- describe decision tree for predicting outcome

## EXAMPLE 7 MULTIPLE VS SINGLETON PREGNANCIES

- describe study examining urine samples from women testing positive for pregnancy

### Study Design, Size, Duration:

- describe study design and size

### Materials, Settings and Methods:

- describe materials and methods used

## EXAMPLE 8 NON-INVASIVE ANALYSIS OF SECRETOME PARAMETERS IN SPENT BLASTOCYST CULTURE MEDIA USING MALDI-TOF MS TO IDENTIFY ANEUPLOIDY: POTENTIAL ALTERNATIVE TO PREIMPLANTATION GENETIC SCREENING

### Objective:

- state objective of identifying aneuploid marker parameters

### Design:

- describe study design

### Materials and Methods:

- describe materials and methods used

### Results:

- present results of secretome pattern differences

### Conclusion:

- conclude non-invasive analysis can identify aneuploid blastocysts

### EXAMPLE 9 NON-INVASIVE ANALYSIS OF SECRETOME PARAMETERS IN SPENT BLASTOCYST CULTURE MEDIA USING MALDI-TOF MS CORRELATES WITH BLASTOCYST GRADING AND PREGNANCY OUTCOME

- state objective of investigating correlations
- conclude non-invasive analysis correlates with blastocyst grading and pregnancy outcome

